US Patent Issued to Cytiva Bioprocess R&D on June 24 for "Chromatography ligand comprising domain c from Staphylococcus aureus protein a for antibody isolation" (Swedish Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,293, issued on June 24, was assigned to Cytiva Bioprocess R&D AB (Uppsala, Sweden).

"Chromatography ligand comprising domain c from Staphylococcus aureus protein a for antibody isolation" was invented by Martin Hall (Uppsala, Sweden), Sture Larsson (Uppsala, Sweden), Andreas Muranyi (Uppsala, Sweden), Gustav Rodrigo (Uppsala, Sweden), Jinyu Zou (Uppsala, Sweden) and Per-Mikael Aberg (Uppsala, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an adva...